Share Price and Basic Stock Data
Last Updated: February 7, 2026, 7:36 pm
| PEG Ratio | 9.06 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Marico Ltd operates in the edible oils and solvent extraction industry, with its current market price standing at ₹722 and a market capitalization of ₹93,774 Cr. The company reported a total sales revenue of ₹9,764 Cr for the fiscal year ending March 2023, which reflects an increase from ₹9,512 Cr in the previous fiscal year. Sales have shown a consistent upward trend, with trailing twelve months (TTM) revenue reaching ₹12,265 Cr. Quarterly sales figures indicate fluctuations, with the latest quarter (Sep 2023) recording sales of ₹2,476 Cr, compared to ₹2,240 Cr in Mar 2023. This demonstrates a recovery and growth trajectory, particularly in the June 2024 quarter, which saw sales peak at ₹2,643 Cr. The company’s ability to maintain a competitive edge in a challenging market is underscored by its diversified product portfolio and strong brand equity, positioning it well within the sector.
Profitability and Efficiency Metrics
Marico’s profitability metrics depict a robust operational performance, with an operating profit margin (OPM) of 17% as of the latest reporting period. The company reported a net profit of ₹1,696 Cr for the fiscal year ending March 2025, demonstrating a steady increase from ₹1,322 Cr in March 2023. The profit before tax for the same fiscal year stood at ₹2,116 Cr, indicating effective cost management and operational efficiency. The return on equity (ROE) is notably high at 41.3%, which is significantly above the industry average, reflecting strong shareholder returns. The interest coverage ratio (ICR) stands at an impressive 44.28x, indicating that Marico comfortably meets its interest obligations. However, the fluctuating OPM percentages—ranging from a high of 24% in June 2024 to a low of 16% in September 2025—highlight potential challenges in maintaining consistent profitability amid changing market dynamics.
Balance Sheet Strength and Financial Ratios
Marico’s balance sheet reflects a solid financial position, with total assets amounting to ₹8,281 Cr and total liabilities at ₹8,281 Cr as of March 2025. The company’s reserves have grown to ₹3,922 Cr, indicating a strong retained earnings position which supports future growth initiatives. With borrowings recorded at ₹575 Cr, Marico exhibits a low debt-to-equity ratio of 0.09, suggesting a conservative capital structure that minimizes financial risk. The company’s current ratio is 2.07, which is well above the industry norm, indicating good liquidity. Additionally, the price-to-book value (P/BV) ratio stands at 21.15x, reflecting high market expectations for future growth. However, the rise in inventory days to 93 days in March 2025, compared to 94 days in March 2024, could suggest potential inefficiencies in inventory management that need addressing.
Shareholding Pattern and Investor Confidence
Marico’s shareholding structure indicates a stable ownership pattern, with promoters holding 58.94% of the equity as of September 2025. Foreign institutional investors (FIIs) account for 24.21%, and domestic institutional investors (DIIs) hold 11.88%, showcasing a diversified investor base that reflects confidence in the company’s governance and strategic direction. The number of shareholders stood at 2,89,152, a slight decrease from the previous quarter, which may signal a consolidation phase among investors. The dividend payout ratio for March 2025 is reported at 27.80%, down from significantly higher levels in prior years, reflecting a shift towards retaining earnings for reinvestment. This could align with the company’s growth strategy, although it may also raise concerns for income-focused investors about the sustainability of dividends going forward.
Outlook, Risks, and Final Insight
Looking ahead, Marico’s growth potential is supported by strong brand recognition and an expanding product range, which are critical for capturing market share in a competitive landscape. However, risks such as fluctuating raw material prices and increased competition in the edible oils sector could impact margins. Additionally, the company’s reliance on domestic markets might expose it to local economic fluctuations. If Marico can effectively manage these challenges while leveraging its operational strengths, it is well-positioned for sustained growth. The focus on innovation and expansion into new product categories will be crucial in maintaining its competitive edge. Ultimately, the strategic decisions made in the near term will significantly influence the company’s trajectory, particularly in balancing growth with profitability.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Modi Naturals Ltd | 435 Cr. | 327 | 610/298 | 11.9 | 107 | 0.00 % | 18.7 % | 29.2 % | 10.0 |
| IEL Ltd | 89.6 Cr. | 6.87 | 10.3/4.00 | 3.37 | 0.00 % | 2.51 % | 1.91 % | 1.00 | |
| Evexia Lifecare Ltd | 310 Cr. | 1.65 | 3.15/1.50 | 217 | 3.02 | 0.00 % | 0.30 % | 0.32 % | 1.00 |
| Diligent Industries Ltd | 58.9 Cr. | 2.47 | 3.95/1.45 | 22.9 | 2.79 | 0.00 % | 7.06 % | 6.09 % | 1.00 |
| CIAN Agro Industries & Infrastructure Ltd | 3,400 Cr. | 1,215 | 3,633/321 | 1,675 | 33.0 | 0.00 % | 8.54 % | 1.06 % | 10.0 |
| Industry Average | 10,166.86 Cr | 159.00 | 133.08 | 37.26 | 0.19% | 14.31% | 12.90% | 4.29 |
Quarterly Result
| Metric | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,470 | 2,240 | 2,477 | 2,476 | 2,422 | 2,278 | 2,643 | 2,664 | 2,794 | 2,730 | 3,259 | 3,482 | 3,537 |
| Expenses | 2,014 | 1,847 | 1,903 | 1,979 | 1,909 | 1,836 | 2,017 | 2,142 | 2,261 | 2,272 | 2,604 | 2,922 | 2,945 |
| Operating Profit | 456 | 393 | 574 | 497 | 513 | 442 | 626 | 522 | 533 | 458 | 655 | 560 | 592 |
| OPM % | 18% | 18% | 23% | 20% | 21% | 19% | 24% | 20% | 19% | 17% | 20% | 16% | 17% |
| Other Income | 40 | 68 | 46 | 38 | 43 | 15 | 37 | 82 | 42 | 47 | 56 | 49 | 39 |
| Interest | 14 | 17 | 17 | 20 | 19 | 17 | 17 | 11 | 13 | 12 | 10 | 12 | 14 |
| Depreciation | 39 | 43 | 36 | 39 | 42 | 41 | 41 | 41 | 44 | 52 | 45 | 47 | 50 |
| Profit before tax | 443 | 401 | 567 | 476 | 495 | 399 | 605 | 552 | 518 | 441 | 656 | 550 | 567 |
| Tax % | 25% | 24% | 23% | 24% | 22% | 20% | 22% | 22% | 22% | 22% | 22% | 21% | 19% |
| Net Profit | 333 | 305 | 436 | 360 | 386 | 320 | 474 | 433 | 406 | 345 | 513 | 432 | 460 |
| EPS in Rs | 2.54 | 2.34 | 3.30 | 2.73 | 2.96 | 2.46 | 3.58 | 3.27 | 3.08 | 2.65 | 3.89 | 3.24 | 3.44 |
Last Updated: February 5, 2026, 1:40 am
Below is a detailed analysis of the quarterly data for Marico Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:
- For Sales, as of Dec 2025, the value is 3,537.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,482.00 Cr. (Sep 2025) to 3,537.00 Cr., marking an increase of 55.00 Cr..
- For Expenses, as of Dec 2025, the value is 2,945.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,922.00 Cr. (Sep 2025) to 2,945.00 Cr., marking an increase of 23.00 Cr..
- For Operating Profit, as of Dec 2025, the value is 592.00 Cr.. The value appears strong and on an upward trend. It has increased from 560.00 Cr. (Sep 2025) to 592.00 Cr., marking an increase of 32.00 Cr..
- For OPM %, as of Dec 2025, the value is 17.00%. The value appears strong and on an upward trend. It has increased from 16.00% (Sep 2025) to 17.00%, marking an increase of 1.00%.
- For Other Income, as of Dec 2025, the value is 39.00 Cr.. The value appears to be declining and may need further review. It has decreased from 49.00 Cr. (Sep 2025) to 39.00 Cr., marking a decrease of 10.00 Cr..
- For Interest, as of Dec 2025, the value is 14.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 12.00 Cr. (Sep 2025) to 14.00 Cr., marking an increase of 2.00 Cr..
- For Depreciation, as of Dec 2025, the value is 50.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 47.00 Cr. (Sep 2025) to 50.00 Cr., marking an increase of 3.00 Cr..
- For Profit before tax, as of Dec 2025, the value is 567.00 Cr.. The value appears strong and on an upward trend. It has increased from 550.00 Cr. (Sep 2025) to 567.00 Cr., marking an increase of 17.00 Cr..
- For Tax %, as of Dec 2025, the value is 19.00%. The value appears to be improving (decreasing) as expected. It has decreased from 21.00% (Sep 2025) to 19.00%, marking a decrease of 2.00%.
- For Net Profit, as of Dec 2025, the value is 460.00 Cr.. The value appears strong and on an upward trend. It has increased from 432.00 Cr. (Sep 2025) to 460.00 Cr., marking an increase of 28.00 Cr..
- For EPS in Rs, as of Dec 2025, the value is 3.44. The value appears strong and on an upward trend. It has increased from 3.24 (Sep 2025) to 3.44, marking an increase of 0.20.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:00 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4,687 | 5,733 | 6,017 | 5,918 | 6,322 | 7,334 | 7,315 | 8,048 | 9,512 | 9,764 | 9,653 | 10,831 | 12,265 |
| Expenses | 3,939 | 4,863 | 4,966 | 4,759 | 5,185 | 6,009 | 5,846 | 6,459 | 7,831 | 7,954 | 7,627 | 8,692 | 10,059 |
| Operating Profit | 748 | 870 | 1,051 | 1,159 | 1,137 | 1,325 | 1,469 | 1,589 | 1,681 | 1,810 | 2,026 | 2,139 | 2,206 |
| OPM % | 16% | 15% | 17% | 20% | 18% | 18% | 20% | 20% | 18% | 19% | 21% | 20% | 18% |
| Other Income | 58 | 59 | 93 | 96 | 85 | 103 | 95 | 107 | 98 | 144 | 142 | 208 | 194 |
| Interest | 34 | 23 | 21 | 17 | 16 | 40 | 50 | 34 | 39 | 56 | 73 | 53 | 47 |
| Depreciation | 77 | 84 | 95 | 90 | 89 | 131 | 140 | 139 | 139 | 155 | 158 | 178 | 188 |
| Profit before tax | 695 | 822 | 1,029 | 1,149 | 1,117 | 1,257 | 1,374 | 1,523 | 1,601 | 1,743 | 1,937 | 2,116 | 2,165 |
| Tax % | 27% | 29% | 30% | 29% | 26% | 10% | 24% | 21% | 22% | 24% | 22% | 22% | |
| Net Profit | 504 | 585 | 723 | 811 | 827 | 1,131 | 1,043 | 1,199 | 1,255 | 1,322 | 1,502 | 1,658 | 1,696 |
| EPS in Rs | 3.76 | 4.45 | 5.51 | 6.19 | 6.31 | 8.63 | 7.91 | 9.08 | 9.48 | 10.07 | 11.44 | 12.57 | 12.86 |
| Dividend Payout % | 46% | 28% | 77% | 57% | 67% | 55% | 85% | 83% | 97% | 45% | 83% | 83% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 16.07% | 23.59% | 12.17% | 1.97% | 36.76% | -7.78% | 14.96% | 4.67% | 5.34% | 13.62% | 10.39% |
| Change in YoY Net Profit Growth (%) | 0.00% | 7.52% | -11.42% | -10.20% | 34.79% | -44.54% | 22.74% | -10.29% | 0.67% | 8.28% | -3.23% |
Marico Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
No data available for the compounded sales growth chart.
Balance Sheet
Last Updated: December 10, 2025, 3:03 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 64 | 64 | 129 | 129 | 129 | 129 | 129 | 129 | 129 | 129 | 129 | 129 | 130 |
| Reserves | 1,296 | 1,760 | 1,888 | 2,197 | 2,414 | 2,846 | 2,894 | 3,111 | 3,219 | 3,670 | 3,703 | 3,846 | 3,922 |
| Borrowings | 680 | 428 | 331 | 239 | 312 | 352 | 338 | 511 | 479 | 608 | 528 | 554 | 575 |
| Other Liabilities | 925 | 873 | 1,010 | 1,059 | 1,217 | 1,569 | 1,603 | 1,675 | 1,850 | 2,393 | 2,993 | 3,752 | 4,052 |
| Total Liabilities | 2,965 | 3,125 | 3,358 | 3,623 | 4,072 | 4,896 | 4,964 | 5,426 | 5,677 | 6,800 | 7,353 | 8,281 | 8,679 |
| Fixed Assets | 888 | 1,076 | 1,050 | 1,085 | 1,110 | 1,300 | 1,396 | 1,612 | 1,760 | 2,246 | 2,724 | 2,758 | 2,791 |
| CWIP | 4 | 3 | 37 | 11 | 27 | 45 | 58 | 24 | 39 | 67 | 44 | 40 | 52 |
| Investments | 311 | 284 | 544 | 608 | 543 | 450 | 733 | 854 | 828 | 1,096 | 602 | 1,590 | 1,394 |
| Other Assets | 1,762 | 1,763 | 1,727 | 1,919 | 2,392 | 3,101 | 2,777 | 2,936 | 3,050 | 3,391 | 3,983 | 3,893 | 4,442 |
| Total Assets | 2,965 | 3,125 | 3,358 | 3,623 | 4,072 | 4,896 | 4,964 | 5,426 | 5,677 | 6,800 | 7,353 | 8,281 | 8,679 |
Below is a detailed analysis of the balance sheet data for Marico Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 130.00 Cr.. The value appears strong and on an upward trend. It has increased from 129.00 Cr. (Mar 2025) to 130.00 Cr., marking an increase of 1.00 Cr..
- For Reserves, as of Sep 2025, the value is 3,922.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,846.00 Cr. (Mar 2025) to 3,922.00 Cr., marking an increase of 76.00 Cr..
- For Borrowings, as of Sep 2025, the value is 575.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 554.00 Cr. (Mar 2025) to 575.00 Cr., marking an increase of 21.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 4,052.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,752.00 Cr. (Mar 2025) to 4,052.00 Cr., marking an increase of 300.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 8,679.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 8,281.00 Cr. (Mar 2025) to 8,679.00 Cr., marking an increase of 398.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 2,791.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,758.00 Cr. (Mar 2025) to 2,791.00 Cr., marking an increase of 33.00 Cr..
- For CWIP, as of Sep 2025, the value is 52.00 Cr.. The value appears strong and on an upward trend. It has increased from 40.00 Cr. (Mar 2025) to 52.00 Cr., marking an increase of 12.00 Cr..
- For Investments, as of Sep 2025, the value is 1,394.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,590.00 Cr. (Mar 2025) to 1,394.00 Cr., marking a decrease of 196.00 Cr..
- For Other Assets, as of Sep 2025, the value is 4,442.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,893.00 Cr. (Mar 2025) to 4,442.00 Cr., marking an increase of 549.00 Cr..
- For Total Assets, as of Sep 2025, the value is 8,679.00 Cr.. The value appears strong and on an upward trend. It has increased from 8,281.00 Cr. (Mar 2025) to 8,679.00 Cr., marking an increase of 398.00 Cr..
Notably, the Reserves (3,922.00 Cr.) exceed the Borrowings (575.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 68.00 | 442.00 | -330.00 | -238.00 | -311.00 | -351.00 | -337.00 | -510.00 | -478.00 | -607.00 | -526.00 | -552.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 17 | 11 | 15 | 15 | 20 | 26 | 27 | 18 | 25 | 38 | 40 | 43 |
| Inventory Days | 151 | 139 | 110 | 193 | 190 | 147 | 157 | 108 | 106 | 94 | 116 | 93 |
| Days Payable | 95 | 79 | 80 | 107 | 103 | 98 | 108 | 109 | 101 | 112 | 137 | 103 |
| Cash Conversion Cycle | 73 | 71 | 46 | 101 | 106 | 74 | 76 | 17 | 30 | 20 | 19 | 33 |
| Working Capital Days | -13 | 18 | 0 | 23 | 37 | 27 | 24 | -11 | 5 | 2 | 14 | 16 |
| ROCE % | 29% | 38% | 44% | 45% | 42% | 42% | 43% | 43% | 43% | 42% | 43% | 45% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| HDFC Mid Cap Fund | 29,425,016 | 2.38 | 2208.64 | 27,125,016 | 2026-01-26 03:03:48 | 8.48% |
| Franklin India Flexi Cap Fund | 4,800,948 | 1.8 | 360.36 | 4,100,000 | 2025-12-08 01:29:31 | 17.1% |
| Sundaram Mid Cap Fund | 3,663,821 | 2.07 | 275.01 | 3,660,354 | 2026-01-26 03:03:48 | 0.09% |
| UTI Flexi Cap Fund | 3,590,000 | 1.08 | 269.47 | 3,624,000 | 2026-01-26 03:03:48 | -0.94% |
| Edelweiss Mid Cap Fund | 3,377,095 | 1.84 | 242.27 | N/A | N/A | N/A |
| Tata Arbitrage Fund | 2,944,800 | 1.1 | 221.04 | 2,901,600 | 2026-01-26 03:03:48 | 1.49% |
| Franklin India Mid Cap Fund | 1,800,000 | 1.05 | 135.11 | N/A | N/A | N/A |
| Franklin India ELSS Tax Saver Fund | 1,733,734 | 1.94 | 130.13 | 1,800,000 | 2025-12-08 01:29:31 | -3.68% |
| UTI Mid Cap Fund | 1,700,000 | 1.07 | 127.6 | N/A | N/A | N/A |
| ICICI Prudential Equity & Debt Fund | 1,662,697 | 0.25 | 124.8 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 12.59 | 11.46 | 10.08 | 9.50 | 9.08 |
| Diluted EPS (Rs.) | 12.56 | 11.43 | 10.05 | 9.49 | 9.08 |
| Cash EPS (Rs.) | 14.23 | 12.87 | 11.45 | 10.81 | 10.39 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 30.81 | 32.32 | 30.67 | 26.40 | 25.26 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 30.81 | 32.32 | 30.67 | 26.40 | 25.26 |
| Revenue From Operations / Share (Rs.) | 83.96 | 74.83 | 75.69 | 73.74 | 62.39 |
| PBDIT / Share (Rs.) | 18.19 | 16.81 | 15.15 | 13.79 | 13.06 |
| PBIT / Share (Rs.) | 16.81 | 15.58 | 13.95 | 12.71 | 11.98 |
| PBT / Share (Rs.) | 16.40 | 15.02 | 13.51 | 12.41 | 11.82 |
| Net Profit / Share (Rs.) | 12.85 | 11.64 | 10.25 | 9.73 | 9.31 |
| NP After MI And SOA / Share (Rs.) | 12.63 | 11.48 | 10.09 | 9.50 | 9.09 |
| PBDIT Margin (%) | 21.66 | 22.45 | 20.01 | 18.70 | 20.93 |
| PBIT Margin (%) | 20.02 | 20.82 | 18.42 | 17.24 | 19.20 |
| PBT Margin (%) | 19.53 | 20.06 | 17.85 | 16.83 | 18.94 |
| Net Profit Margin (%) | 15.30 | 15.55 | 13.53 | 13.19 | 14.92 |
| NP After MI And SOA Margin (%) | 15.04 | 15.34 | 13.33 | 12.87 | 14.56 |
| Return on Networth / Equity (%) | 40.99 | 38.64 | 34.27 | 36.58 | 36.17 |
| Return on Capital Employeed (%) | 36.90 | 40.38 | 39.82 | 45.14 | 44.20 |
| Return On Assets (%) | 19.53 | 19.95 | 18.74 | 21.17 | 21.27 |
| Total Debt / Equity (X) | 0.09 | 0.09 | 0.12 | 0.10 | 0.10 |
| Asset Turnover Ratio (%) | 1.37 | 1.34 | 1.53 | 1.50 | 1.34 |
| Current Ratio (X) | 2.07 | 1.64 | 1.57 | 1.63 | 1.66 |
| Quick Ratio (X) | 1.56 | 1.09 | 1.07 | 0.97 | 1.10 |
| Inventory Turnover Ratio (X) | 8.43 | 3.08 | 3.53 | 3.94 | 2.98 |
| Dividend Payout Ratio (NP) (%) | 27.80 | 82.98 | 44.70 | 97.55 | 82.59 |
| Dividend Payout Ratio (CP) (%) | 25.06 | 74.98 | 39.94 | 87.60 | 73.83 |
| Earning Retention Ratio (%) | 72.20 | 17.02 | 55.30 | 2.45 | 17.41 |
| Cash Earning Retention Ratio (%) | 74.94 | 25.02 | 60.06 | 12.40 | 26.17 |
| Interest Coverage Ratio (X) | 44.28 | 29.70 | 34.89 | 45.62 | 49.56 |
| Interest Coverage Ratio (Post Tax) (X) | 32.28 | 21.58 | 24.61 | 33.18 | 35.94 |
| Enterprise Value (Cr.) | 83930.05 | 63877.10 | 61757.30 | 64793.85 | 52505.50 |
| EV / Net Operating Revenue (X) | 7.75 | 6.62 | 6.33 | 6.81 | 6.52 |
| EV / EBITDA (X) | 35.76 | 29.46 | 31.61 | 36.42 | 31.16 |
| MarketCap / Net Operating Revenue (X) | 7.76 | 6.64 | 6.34 | 6.83 | 6.60 |
| Retention Ratios (%) | 72.19 | 17.01 | 55.29 | 2.44 | 17.40 |
| Price / BV (X) | 21.15 | 16.73 | 16.29 | 19.41 | 16.38 |
| Price / Net Operating Revenue (X) | 7.76 | 6.64 | 6.34 | 6.83 | 6.60 |
| EarningsYield | 0.01 | 0.02 | 0.02 | 0.01 | 0.02 |
After reviewing the key financial ratios for Marico Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 12.59. This value is within the healthy range. It has increased from 11.46 (Mar 24) to 12.59, marking an increase of 1.13.
- For Diluted EPS (Rs.), as of Mar 25, the value is 12.56. This value is within the healthy range. It has increased from 11.43 (Mar 24) to 12.56, marking an increase of 1.13.
- For Cash EPS (Rs.), as of Mar 25, the value is 14.23. This value is within the healthy range. It has increased from 12.87 (Mar 24) to 14.23, marking an increase of 1.36.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 30.81. It has decreased from 32.32 (Mar 24) to 30.81, marking a decrease of 1.51.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 30.81. It has decreased from 32.32 (Mar 24) to 30.81, marking a decrease of 1.51.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 83.96. It has increased from 74.83 (Mar 24) to 83.96, marking an increase of 9.13.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 18.19. This value is within the healthy range. It has increased from 16.81 (Mar 24) to 18.19, marking an increase of 1.38.
- For PBIT / Share (Rs.), as of Mar 25, the value is 16.81. This value is within the healthy range. It has increased from 15.58 (Mar 24) to 16.81, marking an increase of 1.23.
- For PBT / Share (Rs.), as of Mar 25, the value is 16.40. This value is within the healthy range. It has increased from 15.02 (Mar 24) to 16.40, marking an increase of 1.38.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 12.85. This value is within the healthy range. It has increased from 11.64 (Mar 24) to 12.85, marking an increase of 1.21.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 12.63. This value is within the healthy range. It has increased from 11.48 (Mar 24) to 12.63, marking an increase of 1.15.
- For PBDIT Margin (%), as of Mar 25, the value is 21.66. This value is within the healthy range. It has decreased from 22.45 (Mar 24) to 21.66, marking a decrease of 0.79.
- For PBIT Margin (%), as of Mar 25, the value is 20.02. This value exceeds the healthy maximum of 20. It has decreased from 20.82 (Mar 24) to 20.02, marking a decrease of 0.80.
- For PBT Margin (%), as of Mar 25, the value is 19.53. This value is within the healthy range. It has decreased from 20.06 (Mar 24) to 19.53, marking a decrease of 0.53.
- For Net Profit Margin (%), as of Mar 25, the value is 15.30. This value exceeds the healthy maximum of 10. It has decreased from 15.55 (Mar 24) to 15.30, marking a decrease of 0.25.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 15.04. This value is within the healthy range. It has decreased from 15.34 (Mar 24) to 15.04, marking a decrease of 0.30.
- For Return on Networth / Equity (%), as of Mar 25, the value is 40.99. This value is within the healthy range. It has increased from 38.64 (Mar 24) to 40.99, marking an increase of 2.35.
- For Return on Capital Employeed (%), as of Mar 25, the value is 36.90. This value is within the healthy range. It has decreased from 40.38 (Mar 24) to 36.90, marking a decrease of 3.48.
- For Return On Assets (%), as of Mar 25, the value is 19.53. This value is within the healthy range. It has decreased from 19.95 (Mar 24) to 19.53, marking a decrease of 0.42.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.09. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.09.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.37. It has increased from 1.34 (Mar 24) to 1.37, marking an increase of 0.03.
- For Current Ratio (X), as of Mar 25, the value is 2.07. This value is within the healthy range. It has increased from 1.64 (Mar 24) to 2.07, marking an increase of 0.43.
- For Quick Ratio (X), as of Mar 25, the value is 1.56. This value is within the healthy range. It has increased from 1.09 (Mar 24) to 1.56, marking an increase of 0.47.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 8.43. This value exceeds the healthy maximum of 8. It has increased from 3.08 (Mar 24) to 8.43, marking an increase of 5.35.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 27.80. This value is within the healthy range. It has decreased from 82.98 (Mar 24) to 27.80, marking a decrease of 55.18.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 25.06. This value is within the healthy range. It has decreased from 74.98 (Mar 24) to 25.06, marking a decrease of 49.92.
- For Earning Retention Ratio (%), as of Mar 25, the value is 72.20. This value exceeds the healthy maximum of 70. It has increased from 17.02 (Mar 24) to 72.20, marking an increase of 55.18.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 74.94. This value exceeds the healthy maximum of 70. It has increased from 25.02 (Mar 24) to 74.94, marking an increase of 49.92.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 44.28. This value is within the healthy range. It has increased from 29.70 (Mar 24) to 44.28, marking an increase of 14.58.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 32.28. This value is within the healthy range. It has increased from 21.58 (Mar 24) to 32.28, marking an increase of 10.70.
- For Enterprise Value (Cr.), as of Mar 25, the value is 83,930.05. It has increased from 63,877.10 (Mar 24) to 83,930.05, marking an increase of 20,052.95.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 7.75. This value exceeds the healthy maximum of 3. It has increased from 6.62 (Mar 24) to 7.75, marking an increase of 1.13.
- For EV / EBITDA (X), as of Mar 25, the value is 35.76. This value exceeds the healthy maximum of 15. It has increased from 29.46 (Mar 24) to 35.76, marking an increase of 6.30.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 7.76. This value exceeds the healthy maximum of 3. It has increased from 6.64 (Mar 24) to 7.76, marking an increase of 1.12.
- For Retention Ratios (%), as of Mar 25, the value is 72.19. This value exceeds the healthy maximum of 70. It has increased from 17.01 (Mar 24) to 72.19, marking an increase of 55.18.
- For Price / BV (X), as of Mar 25, the value is 21.15. This value exceeds the healthy maximum of 3. It has increased from 16.73 (Mar 24) to 21.15, marking an increase of 4.42.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 7.76. This value exceeds the healthy maximum of 3. It has increased from 6.64 (Mar 24) to 7.76, marking an increase of 1.12.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.02 (Mar 24) to 0.01, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Marico Ltd:
- Net Profit Margin: 15.3%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 36.9% (Industry Average ROCE: 14.31%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 40.99% (Industry Average ROE: 12.9%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 32.28
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.56
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 57 (Industry average Stock P/E: 133.08)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.09
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 15.3%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Edible Oils & Solvent Extraction | 7th Floor, Grande Palladium, 175, CST Road, Mumbai Maharashtra 400098 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Harsh Mariwala | Chairman & Non-Exe.Director |
| Mr. Saugata Gupta | Managing Director & CEO |
| Mr. Nikhil Khattau | Non Executive Director |
| Mr. Rishabh Mariwala | Non Executive Director |
| Mr. Rajendra Mariwala | Non Executive Director |
| Mr. Milind Barve | Lead Independent Director |
| Mr. Ananth Sankaranarayanan | Independent Director |
| Mr. Rajeev Vasudeva | Independent Director |
| Ms. Apurva Purohit | Independent Director |
| Ms. Nayantara Bali | Independent Director |
| Mr. Rajan Bharti Mittal | Independent Director |
FAQ
What is the intrinsic value of Marico Ltd?
Marico Ltd's intrinsic value (as of 08 February 2026) is ₹633.21 which is 15.91% lower the current market price of ₹753.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹97,715 Cr. market cap, FY2025-2026 high/low of ₹780/578, reserves of ₹3,922 Cr, and liabilities of ₹8,679 Cr.
What is the Market Cap of Marico Ltd?
The Market Cap of Marico Ltd is 97,715 Cr..
What is the current Stock Price of Marico Ltd as on 08 February 2026?
The current stock price of Marico Ltd as on 08 February 2026 is ₹753.
What is the High / Low of Marico Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Marico Ltd stocks is ₹780/578.
What is the Stock P/E of Marico Ltd?
The Stock P/E of Marico Ltd is 57.0.
What is the Book Value of Marico Ltd?
The Book Value of Marico Ltd is 31.2.
What is the Dividend Yield of Marico Ltd?
The Dividend Yield of Marico Ltd is 1.39 %.
What is the ROCE of Marico Ltd?
The ROCE of Marico Ltd is 45.2 %.
What is the ROE of Marico Ltd?
The ROE of Marico Ltd is 41.3 %.
What is the Face Value of Marico Ltd?
The Face Value of Marico Ltd is 1.00.